0001144204-09-019131 Sample Contracts

AMENDED AND RESTATED LICENSE AGREEMENT By and Between PRESIDIO PHARMACEUTICALS, INC. And XTL BIOPHARMACEUTICALS LTD.
License Agreement • April 6th, 2009 • XTL Biopharmaceuticals LTD • Pharmaceutical preparations • New York

This Amended and Restated License Agreement (this “Agreement”), dated the 4th day of August, 2008 (the “Restatement Date”), is by and between Presidio Pharmaceuticals, Inc., a Delaware corporation (“PRESIDIO”), and XTL Biopharmaceuticals Ltd., a public company limited by shares organized under the laws of Israel (“XTL”).

AutoNDA by SimpleDocs
AMENDMENT TO THE RESEARCH AND LICENSE AGREEMENT
Research and License Agreement • April 6th, 2009 • XTL Biopharmaceuticals LTD • Pharmaceutical preparations

This Amendment effective as of April 1 2008 (the “Effective Date”) of the Research and License Agreement dated January 7, 2002 (the “Research and License Agreement”) entered into by and between Yeda Research And Development Company Ltd., a company duly registered under the laws of Israel of P.O. Box 95, Rehovot 76100, Israel (“Yeda”), Mor Research Applications Ltd. a company duly registered under the laws of Israel and having its principal place of business at 23 Hasivim Street., Kiryat Matalon, P.O. Box 7590 Petach Tikva 49170 (“Mor”) (Yeda and Mor shall be collectively referred to as the “Licensors”); Biogal Ltd. (under its previous name HaverfieId Ltd)., a company duly registered under the laws of Gibraltar and having its principal place of business at Valmet Nominees Limited Suites 7B & 8B 50 Town Range Gibraltar (the “Company”) and Biogal Advanced Biotechnology Ltd., a company duly registered under the laws of the State of Israel and having its principal place of business at 3 Hay

ASSET PURCHASE AGREEMENT
Asset Purchase Agreement • April 6th, 2009 • XTL Biopharmaceuticals LTD • Pharmaceutical preparations
Contract
Research and License Agreement • April 6th, 2009 • XTL Biopharmaceuticals LTD • Pharmaceutical preparations

CONFIDENTIAL TREATMENT REQUESTED . Confidential portions of this document have been redacted and have been separately filed with the Commission.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!